Mind Medicine (mindmed) INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Definium Therapeutics, Inc. announced its Annual General and Special Meeting of Shareholders will be held virtually on June 11, 2026, to elect directors, appoint auditors, and approve an equity incentive plan amendment.
MindMed will hold its Annual General and Special Meeting virtually on June 12, 2025, with shareholders able to vote on key proposals including the election of directors, appointment of auditors, and approval of the 2025 Equity Incentive Plan.
MindMed announces its Annual General and Special Meeting of Shareholders to be held virtually on June 12, 2025, featuring proposals for director elections, auditor appointment, and approval of a new equity incentive plan.
Mind Medicine (MindMed) Inc. announces its 2024 Annual General and Special Meeting to be held virtually on June 10, 2024, outlining proposals for shareholder voting including the election of directors, appointment of an auditor, and approval of an employee share purchase plan.
MindMed's upcoming annual meeting on June 10, 2024, will address the election of directors, appointment of an auditor, and approval of an employee share purchase plan.